These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 36411639)

  • 1. Deciphering the gut microbiome in neurodegenerative diseases and metagenomic approaches for characterization of gut microbes.
    Singh N; Singh V; Rai SN; Mishra V; Vamanu E; Singh MP
    Biomed Pharmacother; 2022 Dec; 156():113958. PubMed ID: 36411639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of the Gut Microbiota and Microbial Metabolites in the Pathogenesis of Alzheimer's Disease.
    Wang Y
    CNS Neurol Disord Drug Targets; 2023; 22(4):577-598. PubMed ID: 35440320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between the microbiota and enteric nervous system during gut-brain disorders.
    Fried S; Wemelle E; Cani PD; Knauf C
    Neuropharmacology; 2021 Oct; 197():108721. PubMed ID: 34274348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders.
    Chen Y; Xu J; Chen Y
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34205336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut-Brain Axis and Neurodegeneration: State-of-the-Art of Meta-Omics Sciences for Microbiota Characterization.
    Tilocca B; Pieroni L; Soggiu A; Britti D; Bonizzi L; Roncada P; Greco V
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut-Brain Axis Deregulation and Its Possible Contribution to Neurodegenerative Disorders.
    Villavicencio-Tejo F; Olesen MA; Navarro L; Calisto N; Iribarren C; García K; Corsini G; Quintanilla RA
    Neurotox Res; 2023 Dec; 42(1):4. PubMed ID: 38103074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Microbiome-Brain Communication on Neuroinflammation and Neurodegeneration.
    Stolzer I; Scherer E; Süß P; Rothhammer V; Winner B; Neurath MF; Günther C
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human gut microbiota and its association with pathogenesis and treatments of neurodegenerative diseases.
    Chen Z; Maqbool J; Sajid F; Hussain G; Sun T
    Microb Pathog; 2021 Jan; 150():104675. PubMed ID: 33352217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease.
    Kaur G; Behl T; Bungau S; Kumar A; Uddin MS; Mehta V; Zengin G; Mathew B; Shah MA; Arora S
    Curr Neuropharmacol; 2021; 19(2):233-247. PubMed ID: 32504503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal Immunity and the Gut-Microbiota-Brain-Axis in Neuroimmune Disease.
    Sterling KG; Dodd GK; Alhamdi S; Asimenios PG; Dagda RK; De Meirleir KL; Hudig D; Lombardi VC
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjusting for age improves identification of gut microbiome alterations in multiple diseases.
    Ghosh TS; Das M; Jeffery IB; O'Toole PW
    Elife; 2020 Mar; 9():. PubMed ID: 32159510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metagenome-scale community metabolic modelling for understanding the role of gut microbiota in human health.
    Beura S; Kundu P; Das AK; Ghosh A
    Comput Biol Med; 2022 Oct; 149():105997. PubMed ID: 36055158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of gut microbiota in the gut-brain axis: current challenges and perspectives.
    Chen X; D'Souza R; Hong ST
    Protein Cell; 2013 Jun; 4(6):403-14. PubMed ID: 23686721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence.
    Liu X; Liu Y; Liu J; Zhang H; Shan C; Guo Y; Gong X; Cui M; Li X; Tang M
    Neural Regen Res; 2024 Apr; 19(4):833-845. PubMed ID: 37843219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cracking Brain Diseases from Gut Microbes-Mediated Metabolites for Precise Treatment.
    Gong Y; Chen A; Zhang G; Shen Q; Zou L; Li J; Miao YB; Liu W
    Int J Biol Sci; 2023; 19(10):2974-2998. PubMed ID: 37416776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiome-mediated regulation of neuroinflammation.
    Bostick JW; Schonhoff AM; Mazmanian SK
    Curr Opin Immunol; 2022 Jun; 76():102177. PubMed ID: 35462279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of age-related changes in the gut-brain axis to neurological disorders.
    Khan R; Di Gesù CM; Lee J; McCullough LD
    Gut Microbes; 2024; 16(1):2302801. PubMed ID: 38237031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut-brain Axis: Role of Lipids in the Regulation of Inflammation, Pain and CNS Diseases.
    Russo R; Cristiano C; Avagliano C; De Caro C; La Rana G; Raso GM; Canani RB; Meli R; Calignano A
    Curr Med Chem; 2018; 25(32):3930-3952. PubMed ID: 28215162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases.
    Ghaisas S; Maher J; Kanthasamy A
    Pharmacol Ther; 2016 Feb; 158():52-62. PubMed ID: 26627987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.